Lidocaine Patch 5%, 1 patch (63629-8755-20) packaged in 30-count patches per carton (63629-8755-1), Rx only, each patch contains: 700 mg (50mg per gram adhesive) in an aqueous base, Manufactured by: Actavis Laboratories UT, Inc., Relabeled by: Bryant Ranch Prepack, Inc. Burbank, CA 91504 USA

Labeling: Typographical error on the upper left-hand side of the box and individual patch label that has the incorrect dosage form stating, each tablet contains instead of each ad…

Recall #: D-0556-2023
Affected scope: 403 boxes
Initiated: April 20, 2023

Compiled from official public sources by the publisher. · Updated September 2026

Verify with FDA Drug →

View my saved recalls

Bryant Ranch Prepack, Inc. recalled Lidocaine Patch 5%, 1 patch (63629-8755-20) packaged in 30-count patches per carton (6362… - a low-severity action.

Lidocaine Patch 5%, 1 patch (63629-8755-20) packaged in 30-count patches per carton (6362… was recalled by Bryant Ranch Prepack, Inc. in May 10, 2023. Reason: Labeling: Typographical error on the upper left-hand side of the box and individual patch label that has the …. Check the official notice for the remedy. Verify recall #D-0556-2023 with the FDA Drug before acting.

The recall

Bryant Ranch Prepack, Inc. issued this low-severity FDA Drug recall-Labeling: Typographical error on the upper left-hand side of the box and individual patch label that has the ….

Low
severity level: Class III
classification: May 10, 2023
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0556-2023 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Lidocaine Patch 5%, 1 patch (63629-8755-20) packaged in 30-count patches per carton (63629-8755-1), Rx only, each patch contains: 700 mg (50mg per gram adhesive) in an aqueous base, Manufactured by: Actavis Laboratories UT, Inc., Relabeled by: Bryant Ranch Prepack, Inc. Burbank, CA 91504 USA

Reason for recall

Labeling: Typographical error on the upper left-hand side of the box and individual patch label that has the incorrect dosage form stating, each tablet contains instead of each adhesive patch contains.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Low (Class III)
Status	Ongoing
Recall number	D-0556-2023
Date reported	May 10, 2023
Date initiated	April 20, 2023
Recalling firm	Bryant Ranch Prepack, Inc.
Firm location	Burbank, CA
Affected scope	403 boxes
Distribution	Nationwide in the USA

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-0556-2023) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Why was this product recalled? ▼

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on May 10, 2023. Severity: Low. Recall number: D-0556-2023.

Where was the recalled product distributed? ▼

Distribution: Nationwide in the USA.

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Low), closest by report date among other firms and states.

Signature Select Oat & Nuts Bread NET WT … 2023-05-10 Signature Select Nuts & Grain Bread NET W… 2023-05-10 Gabapentin Tablets, USP 600 mg, packaged … 2023-05-17 Avicel PH-101 NF, Microcrystalline Cellul… 2023-05-03

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Montelukast Sodium USP, 10 mg, 30 count-b… 2023-05-10 Glimepiride USP, 4 mg, 90 count-bottles, … 2023-05-10 Simvastatin USP 20 mg, Rx only, Intas Pha… 2023-05-10 Seatex Alcohol Antiseptic 80% Topical Sol… 2023-05-10

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported May 10, 2023. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026